PRMT5-IN-19
PRMT5-IN-19 (Compound 41) is an selective orally active non-nucleoside PRMT5 inhibitor with IC50 values of 23.9 nM (radioactive biochemical assay) and 47 nM (AlphaLISA assay) . PRMT5-IN-19 can occupy the SAM-binding pocket in PRMT5 and block methyltransferase activity, which displays good selectivity over other PRMTs and PKMTs. PRMT5-IN-19 inhibits cell proliferation by inducing cell apoptosis, and can be used for cancer-related research[1].
Product Specifications
CAS Number
2783961-86-2
UNSPSC
12352005
Target
Histone Methyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/prmt5-in-19.html
Solubility
10 mM in DMSO
Smiles
C[C@H](OC1=CC=C(C2=CC3=C(N=CN=C3N2)C4=CCNCC4)C=C1)C5=CC=CC=C5
Molecular Formula
C25H24N4O
Molecular Weight
396.48
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PRMT1; PRMT4; PRMT5
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Spermidine or Spermine N1-Acetyltransferase 1 (CPTC-SAT1-3), CF405S conjugate, 0.1mg/mL
Glutamyl Prolyl tRNA synthetase (EPRS) Human Gene Knockout Kit (CRISPR)
